SEHK:9969Biotechs
InnoCare Pharma (SEHK:9969) Stock Jumps As Profit Arrives And Pipeline Risk Persists
InnoCare Pharma stock comes into this earnings story with a strong backdrop, up about 27% over the past three months and closing at HK$14.91 on 25 August. The headline today is simple: the market is reacting to a biopharma that has shifted from losses to profit while still leaning hard into research and development.
The emotional tug of war sits between a clean profit print and what it took to get there. Second quarter revenue reached RMB 608.4m and basic earnings per share came in at RMB...